The UK Government has set out a plan to fight antimicrobial resistance (AMR) in the country by 2040, with an aim to cut down antibiotics use by 15% over the...
24 January 2019 News
15 January 2019 News
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China.
14 January 2019 News
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to...
26 December 2018 Comment
GlobalData believes that mRNA vaccines may be more favourable to DNA vaccines because they do not have to overcome the nuclear membrane before transcription.
19 December 2018 Analysis
Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus
In this issue: A new class of cancer combo treatments, antidepressants in the environment, microbiome-based drug development, and more.
18 December 2018 News
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life cycle management.
13 December 2018 News
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund HIV care and prevention research in the southern US.
10 December 2018 News
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and Imperial College London have formed an alliance to develop new vaccines against known as well as unknown pathogens, which are...
3 December 2018 News
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.